91 related articles for article (PubMed ID: 178796)
1. Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein.
Curtiss LK; Edgington TS
J Immunol; 1976 May; 116(5):1452-8. PubMed ID: 178796
[TBL] [Abstract][Full Text] [Related]
2. Effect of LDL-In, a normal immunoregulatory human serum low density lipoprotein, on the interaction of macrophages with lymphocytes proliferating in response to mitogen and allogeneic stimulation.
Curtiss LK; Edgington TS
J Immunol; 1977 Jun; 118(6):1966-70. PubMed ID: 193990
[TBL] [Abstract][Full Text] [Related]
3. Identification of a lymphocyte surface receptor for low density lipoprotein inhibitor, an immunoregulatory species of normal human serum low density lipoprotein.
Curtiss LK; Edgington TS
J Clin Invest; 1978 May; 61(5):1298-308. PubMed ID: 207735
[TBL] [Abstract][Full Text] [Related]
4. Differential sensitivity of lymphocyte subpopulations to suppression by low density lipoprotein inhibitor, an immunoregulatory human serum low density lipoprotein.
Curtiss LK; Edgington TS
J Clin Invest; 1979 Feb; 63(2):193-201. PubMed ID: 219033
[TBL] [Abstract][Full Text] [Related]
5. Direct suppression of lymphocyte induction by the immunoregulatory human serum low density lipoprotein, LDL-In.
Fujii DK; Edgington TS
J Immunol; 1980 Jan; 124(1):156-60. PubMed ID: 6444224
[TBL] [Abstract][Full Text] [Related]
6. Differences in the characteristics of inhibition of lymphocyte stimulation by 25-hydroxycholesterol and by the immunoregulatory serum lipoprotein LDL-In.
Curtiss LK; Edgington TS
J Immunol; 1980 Oct; 125(4):1470-4. PubMed ID: 7410845
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In.
Pepe MG; Curtiss LK
J Immunol; 1986 May; 136(10):3716-23. PubMed ID: 3701060
[TBL] [Abstract][Full Text] [Related]
8. In vivo suppression of the primary immune response by a species of low density serum lipoprotein.
Curtiss LK; DeHeer DH; Edgington TS
J Immunol; 1977 Feb; 118(2):648-52. PubMed ID: 190318
[TBL] [Abstract][Full Text] [Related]
9. Regulation of low density lipoprotein receptor activity in freshly isolated human lymphocytes.
Ho YK; Brown S; Bilheimer DW; Goldstein JL
J Clin Invest; 1976 Dec; 58(6):1465-74. PubMed ID: 186492
[TBL] [Abstract][Full Text] [Related]
10. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.
Tertov VV; Sobenin IA; Gabbasov ZA; Popov EG; Jaakkola O; Solakivi T; Nikkari T; Smirnov VN; Orekhov AN
Lab Invest; 1992 Nov; 67(5):665-75. PubMed ID: 1434544
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte E rosette inhibitory factor: a regulatory serum lipoprotein.
Chisari FV; Edgington TS
J Exp Med; 1975 Nov; 142(5):1092-1107. PubMed ID: 172585
[TBL] [Abstract][Full Text] [Related]
12. The biologic activity of the immunoregulatory lipoprotein, LDL-In is independent of its free fatty acid content.
Curtiss LK; Edgington TS
J Immunol; 1981 Apr; 126(4):1382-6. PubMed ID: 7204969
[TBL] [Abstract][Full Text] [Related]
13. Immunoregulatory plasma low density lipoprotein: the biologic activity and receptor-binding specificity is independent of neutral lipids.
Curtiss LK; Edgington TS
J Immunol; 1981 Mar; 126(3):1008-12. PubMed ID: 7462623
[TBL] [Abstract][Full Text] [Related]
14. Surface properties of LDL-binding lymphocytes in human peripheral blood.
Hiramatsu K; Sakai H; Endoh M; Arimori S
Immunology; 1980 Mar; 39(3):311-6. PubMed ID: 6969214
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive activity of serum lipoproteins from patients with idiopathic nephrotic syndrome.
Inoue K; Yamashita U; Yamashita F
Jpn J Exp Med; 1984 Apr; 54(2):73-80. PubMed ID: 6471527
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by membrane-bound low-density lipoproteins of the primary inductive events of mitogen-stimulated lymphocyte activation.
Harmony JA; Hui DY
Cancer Res; 1981 Sep; 41(9 Pt 2):3799-802. PubMed ID: 6266668
[TBL] [Abstract][Full Text] [Related]
17. Mathematical evaluation of methods for estimation of the concentration of the major lipid components of human serum lipoproteins.
Myers LH; Phillips NR; Havel RJ
J Lab Clin Med; 1976 Sep; 88(3):491-505. PubMed ID: 182891
[TBL] [Abstract][Full Text] [Related]
18. The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.
Manzato E; Marin R; Gasparotto A; Baggio G; Fellin R; Crepaldi G
J Lab Clin Med; 1984 Nov; 104(5):778-88. PubMed ID: 6491471
[TBL] [Abstract][Full Text] [Related]
19. Serum low density lipoprotein separation: a simple procedure.
Graziani MS; Dimitri G; Lippi U
Med Lab Sci; 1992 Mar; 49(1):83-4. PubMed ID: 1453914
[TBL] [Abstract][Full Text] [Related]
20. Cord blood plasma lipoproteins inhibit mitogen-stimulated lymphocyte proliferation.
Curtiss LK; Forte TM; Davis PA
J Immunol; 1984 Sep; 133(3):1379-84. PubMed ID: 6430997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
